Business
Sickest coronavirus patients to be treated with arthritis drugs after study finds reduction in death rates – ABC News
A study finds treating critically ill COVID-19 patients with Roche’s Actemra or Sanofi’s Kevzara arthritis drugs significantly improves survival rates and reduces…
A study has found treating critically ill COVID-19 patients with Roche’s Actemra or Sanofi’s Kevzara arthritis drugs significantly improves survival rates and reduces the amount of time patients need intensive care.
Key points:
- The study involved 800 severely ill COVID-19 patients
- The UK Government said the drugs will be used to treat critically ill COVID-19 patients
- Results showed that on average, patients treated with Actemra or Kevzara recovered more swiftly
The findings, which have not yet been…
-
Noosa News19 hours agoMega-team of heavy horses sets world record at Good Old Days Festival
-
General23 hours agoEnglish springer spaniels Kelly and Milo helping fight dieback in Western Australia
-
Noosa News12 hours agoNRL grand final quick hits: Reece Walsh creates magic after avoiding sin bin as Broncos survive Hunt, Reynolds injuries to win premiership
-
General12 hours agoHow the internet reacted to Brisbane Broncos winning the NRL grand final